USPTO serial 79447060
PAVEWAY
Reviewed by CopyMark Law Group
Status 645Office Action
- Filing date
- Status date
- Registration date
- —
- Examiner
- CARR, PATRICK C
- Law office
- TMO LAW OFFICE 125
What this means
The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.
Need help with PAVEWAY?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Office Action, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Allisen Pawlenty
Allisen Pawlenty Coates IP LLP3057 Nutley St. #801Fairfax, VA 22031United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemicals used in industry and science; cell cultures used in industry and science; biological preparations for use in science; biological preparations for use in cell cultures, other than for medical or veterinary purposes; proteins for industrial use in the manufacture of enzymes; microbial preparations being chemicals for industry; cultures of microorganisms other than for medical or veterinary use; chemical reagents, other than for medical or veterinary purposes; organic chemicals for use in science, namely genes being DNA sequences; plasmids being small independently replicating pieces of DNA and vectors being small independently replicating pieces of DNA that can transfer DNA sequences, being chemicals for use in science; cell culture reagents for scientific and research use; media for cell culture for use in the biotechnological industry, other than for medical or veterinary use; chemicals for use in biotechnological product development; chemicals for use in biotechnological manufacturing processes. | ACTIVE | — |
| 040 | Processing and manufacturing of chemicals and proteins; custom manufacture of chemicals and proteins for use in biotechnology and pharmaceuticals; manufacture, processing and production of scientific and industrial products, namely, recombinant proteins for use in the biotechnology industries, to the order and specification of others; custom processing and manufacturing services of chemicals and proteins; custom processing and manufacturing of biological products; custom manufacture of biopharmaceuticals; manufacture, processing and production of recombinant proteins for use in the biotechnology industries to the order and specification of others; cell culture manufacturing services for others; custom manufacture of biologics; information, advice and consultancy in relation to all the aforesaid. | ACTIVE | — |
| 042 | Scientific, industrial and technical research in the fields of biomanufacturing, bioprocessing, biopharmaceuticals and pharmaceuticals; scientific analysis in the fields of biomanufacturing, bioprocessing, biopharmaceuticals and pharmaceuticals; technological analysis services in the fields of biomanufacturing, bioprocessing, biopharmaceuticals and pharmaceuticals; scientific research and development; industrial process development in the fields of biomanufacturing, bioprocessing, biopharmaceuticals and pharmaceuticals; industrial design services; provision of facilities for scientific, industrial and technical research and development in the fields of biomanufacturing, bioprocessing, biopharmaceuticals and pharmaceuticals; research and development of scientific, industrial and technical products; technical project studies in the fields of biomanufacturing, bioprocessing, biopharmaceuticals and pharmaceuticals; testing of scientific, industrial and technical products in the fields of biomanufacturing, bioprocessing, biopharmaceuticals and pharmaceuticals; scientific research and industrial research in the fields of biomanufacturing, bioprocessing, biopharmaceuticals and pharmaceuticals, and technical product research and development services in the field of biotechnology; development of processes for the use in the manufacture of biotechnology products; technical project studies in the fields of biomanufacturing, bioprocessing, biopharmaceuticals and pharmaceuticals; biotechnology product testing services; scientific research and consultancy in the field of biotechnology; scientific research and development in the pharmaceutical and biotechnology industry; development of processes for use in the manufacture of pharmaceuticals; biopharmaceutical product development; design and development of manufacturing processes in the field of biopharmaceuticals; development of chemicals for use in the manufacture of biotechnology products and pharmaceuticals; preparation of biological samples for analysis in research laboratories; information, advice and consultancy in relation to all the aforesaid. | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 4, 2026 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Aug 4, 2026 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Aug 4, 2026 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jul 22, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 22, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 22, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 2, 2026 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Jul 2, 2026 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 2, 2026 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jul 2, 2026 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Jul 2, 2026 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Jun 18, 2026 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jun 2, 2026 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jun 2, 2026 | RFRR | REFUSAL PROCESSED BY MPU | — |
| May 7, 2026 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Apr 21, 2026 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Apr 20, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 4, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 3, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Apr 3, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 2, 2026 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |